Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Country Focus: Healthcare, Regulatory and Reimbursement Landscape – Thailand

Friday, February 10, 2017 8:45
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by Publisher’s team of industry experts.

For more information at http://www.reportsweb.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-thailand .

In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%.

The positive trends in the healthcare market of Thailand can be attributed primarily to - 
- Increasing medical tourism
- Increasing health awareness
- Greater access to life-saving facilities

Report Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes - 
- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.
- An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
- An overview of the opportunities and challenges for growth in the healthcare market

Request Sample Copy: http://www.reportsweb.com/inquiry&RW0001506947/sample .

Reasons to buy

This report will enhance your decision-making capability by allowing you to - 
- Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001506947/buying .

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.